Humor Urban Legends RFID Microchip Implants Required Under Obamacare? Share PINTEREST Email Print MirageC/Getty Images Urban Legends Rumors & Hoaxes Urban Legends in the News Classic & Historic Legends Animal Folklore Scary Stories By David Emery David Emery is an internet folklore expert, and debunker of urban legends, hoaxes, and popular misconceptions. He currently writes for Snopes.com. our editorial process David Emery Updated February 19, 2019 Since 2009, various versions have circled the internet (primarily via false forwarded emails) of a rumor that the US government was going to begin requiring citizens to have a have a microchip embedded in them under Obamacare. This was and still is completely false. Example of the rumor:Email contributed by Sherry F., Feb. 11, 2013: Micro Chip Implant Coming March 23, 2013The New Health Care (Obama care) law H.R. 3590 Also HR 4872 requires all US citizens to... have the RIFD implantedThis evil plan is being launched by America. its a micro chip injected in your hand. it will contain all your personal data heath and bank accounts etc. its also a GPS device being monitored. they can deactivate it at any time if they find you suspicious or not loyal to their government or go against them or their system and you will lose everything you ever had. soon this device will be made common just like they did credit cards, turning paper money into digital money. means nothing is physically in your hand. it will be made a must for every citizen with time according to their plan and then they will spread it outside America so they can monitor and control as many people as they can and turn them into slaves with their digital technologies.this device is the future or slaveryBEWARE of this EVIL DEVICE. if you don't believe me do your own research before you come to argue or debate.warn more people create this awareness do more research on your own and save yourself from this NEW DEVILRY. 01 of 02 Obamacare and Microchip Implants It's true that an early draft of what came to be known as the Patient Protection and Affordable Care Act ("Obamacare") would have established a national medical device registry to track the safety and efficacy of all kinds of medical devices including, but not limited to, "implantable, life-supporting, or life-sustaining" ones (such as heart pacemakers, stents, neurostimulators, ophthalmic devices, drug delivery systems, and biometric monitors). It did not mandate the use of any such devices, however. Let that be repeated: It did not mandate the use of any such devices. Nowhere in any version of the health care bill did it say Americans must have microchips or any other devices implanted anywhere in their bodies. The only thing the proposed registry was designed to "track" was the efficacy and safety of medical devices. In any case, the provision that would have created the national medical device registry was entirely stricken from the final legislation signed into law by President Obama. Misconstrued and Misrepresented The language in bills such as this is dense, technical, and sometimes hard to decipher. It is easy to misconstrue, and therefore easy to misrepresent. For example, one internet posting quotes part of the stricken passage about a national medical device registry and claims it stipulates that "all Americans may be compelled to receive a microchip, similar to that used in the identification and control of animals, in order to receive State mandated health care." The enacted version of the Patient Protection and Affordable Care Act contains no mention of implantable medical devices at all, much less implantable RFID chips, much less a provision requiring all U.S. citizens to have them. Source Documents H.R. 3200: Establishment of National Medical Device Registry (excerpt)H.R. 3200: America’s Affordable Health Choices Act of 2009 (not enacted)H.R. 3590: Patient Protection and Affordable Care Act (enacted March 23, 2010)Chain Email Says Those on Public Option Will Have to Get Microchip ImplantPolitifact.com, 23 November 2009Will Americans Receive a Microchip Implant in 2013 Per Obamacare?NewsWithViews.com, 23 July 2012Objection to Microchip Implant by United States Government Health Care (Obamacare)Freedom's Phoenix, 25 October 2012 02 of 02 Excerpt From 'H.R. 3200: America’s Affordable Health Choices Act of 2009' The following language appeared under Subtitle C of an early draft (not the final version) of the legislation ultimately passed under the title "Patient Protection and Affordable Care Act" (now more commonly known as "Obamacare"). Nowhere does it state that anyone is required to receive implants of any kind, including RFID microchip implants. Moreover, this passage was not included in the final bill signed into law by President Obama in 2010. ‘National Medical Device Registry ‘(g)(1) The Secretary shall establish a national medical device registry (in this subsection referred to as the ‘registry’) to facilitate analysis of postmarket safety and outcomes data on each device that-- ‘(A) is or has been used in or on a patient; and ‘(B) is-- ‘(i) a class III device; or ‘(ii) a class II device that is implantable, life-supporting, or life-sustaining. ‘(2) In developing the registry, the Secretary shall, in consultation with the Commissioner of Food and Drugs, the Administrator of the Centers for Medicare & Medicaid Services, the head of the Office of the National Coordinator for Health Information Technology, and the Secretary of Veterans Affairs, determine the best methods for-- ‘(A) including in the registry, in a manner consistent with subsection (f), appropriate information to identify each device described in paragraph (1) by type, model, and serial number or other unique identifier; ‘(B) validating methods for analyzing patient safety and outcomes data from multiple sources and for linking such data with the information included in the registry as described in subparagraph (A), including, to the extent feasible, use of-- ‘(i) data provided to the Secretary under other provisions of this chapter; and ‘(ii) information from public and private sources identified under paragraph (3); ‘(C) integrating the activities described in this subsection with-- ‘(i) activities under paragraph (3) of section 505(k) (relating to active postmarket risk identification); ‘(ii) activities under paragraph (4) of section 505(k) (relating to advanced analysis of drug safety data); and ‘(iii) other postmarket device surveillance activities of the Secretary authorized by this chapter; and ‘(D) providing public access to the data and analysis collected or developed through the registry in a manner and form that protects patient privacy and proprietary information and is comprehensive, useful, and not misleading to patients, physicians, and scientists. ‘(3)(A) To facilitate analyses of postmarket safety and patient outcomes for devices described in paragraph (1), the Secretary shall, in collaboration with public, academic, and private entities, develop methods to-- ‘(i) obtain access to disparate sources of patient safety and outcomes data, including-- ‘(I) Federal health-related electronic data (such as data from the Medicare program under title XVIII of the Social Security Act or from the health systems of the Department of Veterans Affairs); ‘(II) private sector health-related electronic data (such as pharmaceutical purchase data and health insurance claims data); and ‘(III) other data as the Secretary deems necessary to permit postmarket assessment of device safety and effectiveness; and ‘(ii) link data obtained under clause (i) with information in the registry. ‘(B) In this paragraph, the term ‘data’ refers to information respecting a device described in paragraph (1), including claims data, patient survey data, standardized analytic files that allow for the pooling and analysis of data from disparate data environments, electronic health records, and any other data deemed appropriate by the Secretary. ‘(4) Not later than 36 months after the date of the enactment of this subsection, the Secretary shall promulgate regulations for establishment and operation of the registry under paragraph (1). Such regulations-- ‘(A)(i) in the case of devices that are described in paragraph (1) and sold on or after the date of the enactment of this subsection, shall require manufacturers of such devices to submit information to the registry, including, for each such device, the type, model, and serial number or, if required under subsection (f), other unique device identifier; and ‘(ii) in the case of devices that are described in paragraph (1) and sold before such date, may require manufacturers of such devices to submit such information to the registry, if deemed necessary by the Secretary to protect the public health; ‘(B) shall establish procedures-- ‘(i) to permit linkage of information submitted pursuant to subparagraph (A) with patient safety and outcomes data obtained under paragraph (3); and ‘(ii) to permit analyses of linked data; ‘(C) may require device manufacturers to submit such other information as is necessary to facilitate postmarket assessments of device safety and effectiveness and notification of device risks; ‘(D) shall establish requirements for regular and timely reports to the Secretary, which shall be included in the registry, concerning adverse event trends, adverse event patterns, incidence and prevalence of adverse events, and other information the Secretary determines appropriate, which may include data on comparative safety and outcomes trends; and ‘(E) shall establish procedures to permit public access to the information in the registry in a manner and form that protects patient privacy and proprietary information and is comprehensive, useful, and not misleading to patients, physicians, and scientists. ‘(5) To carry out this subsection, there are authorized to be appropriated such sums as may be necessary for fiscal years 2010 and 2011.’. (2) EFFECTIVE DATE- The Secretary of Health and Human Services shall establish and begin implementation of the registry under section 519(g) of the Federal Food, Drug, and Cosmetic Act, as added by paragraph (1), by not later than the date that is 36 months after the date of the enactment of this Act, without regard to whether or not final regulations to establish and operate the registry have been promulgated by such date. (3) CONFORMING AMENDMENT- Section 303(f)(1)(B)(ii) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 333(f)(1)(B)(ii)) is amended by striking ‘519(g)’ and inserting ‘519(h)’. (b) Electronic Exchange and Use in Certified Electronic Health Records of Unique Device Identifiers- (1) RECOMMENDATIONS- The HIT Policy Committee established under section 3002 of the Public Health Service Act (42 U.S.C. 300jj-12) shall recommend to the head of the Office of the National Coordinator for Health Information Technology standards, implementation specifications, and certification criteria for the electronic exchange and use in certified electronic health records of a unique device identifier for each device described in section 519(g)(1) of the Federal Food, Drug, and Cosmetic Act, as added by subsection (a). (2) STANDARDS, IMPLEMENTATION CRITERIA, AND CERTIFICATION CRITERIA- The Secretary of the Health Human Services, acting through the head of the Office of the National Coordinator for Health Information Technology, shall adopt standards, implementation specifications, and certification criteria for the electronic exchange and use in certified electronic health records of a unique device identifier for each device described in paragraph (1), if such an identifier is required by section 519(f) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360i(f)) for the device.